Navigation Links
Perrigo Reports Record Third Quarter
Date:5/7/2009

.50 $0.47 $1.36 $1.18 Diluted Shares 93,153 94,955 93,747 95,115

Third Quarter Results

Net sales from continuing operations for the third quarter of fiscal 2009 were $505.9 million, an increase of 5%. Reported income from continuing operations was $46.5 million, or $0.50 per share, compared with $40.2 million, or $0.42 per share, a year ago, an increase of 16%. Excluding charges as outlined in Table II at the end of this release, third quarter fiscal 2009 adjusted income from continuing operations was $47.0 million, or $0.50 per share.

(Refer to Table II at the end of this press release for additional adjustments in the current year period and additional non-GAAP disclosure information.)

As part of management's strategic review of its portfolio of businesses, in March 2009, the Company committed to a plan to sell its Israel Consumer Products business. The results of this business are reflected in the condensed consolidated financial statements as discontinued operations for all periods presented. The Company has engaged the investment banking firms of William Blair and Poalim Capital Markets to assist in this sale process, which is expected to be completed within one year.

Perrigo's Chairman and CEO Joseph C. Papa stated, "I am very pleased with our record third quarter sales and earnings. In this quarter, the over-the-counter category fell 3% versus third quarter last year and the national brand category fell more than 7%, while Perrigo Consumer Healthcare grew 12%. We were able to achieve this growth rate despite the fact that we are comparing the results to the launches of Omeprazole and Cetirizine at this time last year. More consumers than ever are realizing the value that store brands have to offer."

Nine Months Results

Net sales from continuing operations for the first nin
'/>"/>

SOURCE Perrigo Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine news :

1. Perrigo Vice Chair Mori Arkin To Retire After 30 Years of Service
2. Perrigo Company to Host Analyst Meeting on September 18, 2007
3. Perrigo Company Announces FDA Approval for Ciclopirox Topical Solution
4. Perrigo Company Announces FDA Approval for Ciclopirox Topical Solution
5. Perrigo Confirms Filing for Generic Version of Mucinex(R) and Announcement of Lawsuit by Adams Respiratory
6. Perrigo Company Will Release First Quarter Fiscal 2008 Results on November 1, 2007
7. Perrigo Company Announces Dividend Increase
8. Perrigo Announces that Dexcels Settlement with AstraZeneca Allows OTC Omeprazole Launch Following Final FDA Approval
9. Perrigo Company to Present at The 26th Annual JPMorgan Healthcare Conference
10. Perrigo Acquires UK OTC Store Brand Supplier
11. Perrigo Company Authorizes Continuation of Share Repurchase Program and Announces Quarterly Dividend
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... Miami, FL (PRWEB) , ... July 29, 2015 , ... ... on fruit flies revealed a gene which is directly responsible for stimulating and perpetuating ... was published in the journal entitled Proceedings of the National academy of Sciences, and ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... testing regulations imposed by the FDA for nicotine laced liquid products. Their report ... cigarettes have raised considerably. E-Cigarettes are particularly troublesome to addiction professionals as many ...
(Date:7/29/2015)... ... July 29, 2015 , ... CrossFit 269, offering ... July to Kalamazoo Strength & Conditioning. , The name change coincides with the ... of our training center over the past three years,” according to Jack Kelly, ...
(Date:7/29/2015)... ... July 29, 2015 , ... San Fernando Valley ... Ultherapy. For a limited time only, patients can get the complete treatment process with ... patients who prefer a non-invasive treatment and have loose or sagging skin. , ...
(Date:7/29/2015)... ... ... For the second year in a row, the management and staff of Vast ... companies in Jacksonville. This annual list is compiled by the Jacksonville Business Journal, a ... Bridges staffers were on hand to receive the award naming the company the 16th ...
Breaking Medicine News(10 mins):Health News:Study Reveals Potential for Gene Manipulation to Stop Alcohol Addiction 2Health News:Study Reveals Potential for Gene Manipulation to Stop Alcohol Addiction 3Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 2Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 3Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 2Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 3Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 4Health News:San Fernando Valley Dermatology Office, Castle Dermatology Institute, is Now Offering a Promotional Price on Ultherapy 2Health News:Vast Bridges Continues Its Swift Growth 2
... Patients with a certain gene variant drank less ... without the variant while taking the medication naltrexone, ... National Institutes of Health,s 2001-2004 COMBINE (Combined Pharmacotherapies ... About 87 percent of patients with the variant ...
... Fourth Consecutive Quarterly ... Revenue Increase Over Prior Year, SAN DIEGO, Feb. 7 ... today reported financial results for its fourth quarter and,fiscal 2007. Operating ... Vermed which was sold on August 31, 2007., Key Financial ...
... Memory Pharmaceuticals,Corp. (Nasdaq: MEMY ) today ... President & Chief Executive Officer. In support of ... MPM,Capital, Great Point Partners, Oxford Biosciences and Venrock, ... who has served as the,Company,s President & Chief ...
... Finding Health and Mental Health Top the List,of Needs, ... series of tornadoes in decades, many people across the ... Cross continues to help,provide meals, shelter and clean up ... welcome help comes from Red Cross health and mental,health ...
... products for infants , , THURSDAY, Feb. 7 (HealthDay News) ... Canada are calling for a ban on the use ... toddler sippy cups, water bottles and other food and ... polycarbonate bottles [investigated in the study] leached BPA when ...
... What began as a healthy family,recipe for a ... people of all,ages. Triathlete Erin DeMarines, founder of 10-year-old ... 3Bar might have gotten its,start with DeMarines, "friends and ... now available in over 200 retail stores including Publix ...
Cached Medicine News:Health News:Gene variant predicts medication response in patients with alcohol dependence 2Health News:Gene variant predicts medication response in patients with alcohol dependence 3Health News:CardioDynamics Reports Fourth Quarter and Fiscal 2007 Results with 10% Revenue Growth in 2007 2Health News:CardioDynamics Reports Fourth Quarter and Fiscal 2007 Results with 10% Revenue Growth in 2007 3Health News:CardioDynamics Reports Fourth Quarter and Fiscal 2007 Results with 10% Revenue Growth in 2007 4Health News:CardioDynamics Reports Fourth Quarter and Fiscal 2007 Results with 10% Revenue Growth in 2007 5Health News:CardioDynamics Reports Fourth Quarter and Fiscal 2007 Results with 10% Revenue Growth in 2007 6Health News:CardioDynamics Reports Fourth Quarter and Fiscal 2007 Results with 10% Revenue Growth in 2007 7Health News:Memory Pharmaceuticals Appoints Vaughn M. Kailian Interim President & Chief Executive Officer 2Health News:Memory Pharmaceuticals Appoints Vaughn M. Kailian Interim President & Chief Executive Officer 3Health News:Memory Pharmaceuticals Appoints Vaughn M. Kailian Interim President & Chief Executive Officer 4Health News:Tornado-Scarred States Receive American Red Cross Health Services 2Health News:Tornado-Scarred States Receive American Red Cross Health Services 3Health News:Report Shows Dangerous Chemical Can Leach From Baby Bottles 2Health News:Report Shows Dangerous Chemical Can Leach From Baby Bottles 3Health News:New Natural Energy Bar Hits the Road with Dieters & Athletes Alike 2
(Date:7/29/2015)... 2015  Depomed, Inc. (Nasdaq: DEPO ) today ... quarter ended June 30, 2015. "Depomed has ... neurology marketplace, with significant net product revenue growth that ... our shareholders in both the immediate and long term," ... in the second quarter was led by our flagship ...
(Date:7/29/2015)... REDMOND, Washington , 29 luglio 2015 /PRNewswire/ ... tedesco ha scoperto che l,ingestione quotidiana del probiotico ... microbiota intestinale umano e modifica la produzione intestinale ... insulina. Lo studio riguardava la somministrazione quotidiana di ceppo ... ATCC SD-5865) in compresse utilizzando il sistema di ...
(Date:7/29/2015)... July 29, 2015   Turing Pharmaceuticals AG ... joined the company as its first Chief Communication Officer. ... have overall responsibility for internal and external communications and ... He will report directly to Founder and Chairman, ... Leadership Team. "We are excited to have ...
Breaking Medicine Technology:Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 Guidance 2Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 Guidance 3Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 Guidance 4Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 Guidance 5Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 Guidance 6Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 Guidance 7Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 Guidance 8Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 Guidance 9Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 Guidance 10Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 Guidance 11Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 Guidance 12Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 Guidance 13Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 Guidance 14Depomed Reports Record Sales and Cash Flow in Second Quarter 2015 and Raises Full Year 2015 Guidance 15È stato clinicamente dimostrato che il probiotico L. reuteri di Nutraceutix regola il metabolismo insulinico intestinale 2Turing Pharmaceuticals Names Craig Rothenberg Chief Communication Officer 2Turing Pharmaceuticals Names Craig Rothenberg Chief Communication Officer 3
... Targeted Genetics,Corporation (Nasdaq: TGEN ) announced ... study demonstrate that tgAAC94, its investigational agent,designed to ... mediator of inflammation, is well tolerated and may ... other therapies,including systemic TNF antagonists. Full results of ...
... June 11 /PRNewswire-FirstCall/,-- Iomai Corporation (Nasdaq: IOMI ... company,s positive Phase II field study of its ... analyzed data from 170 travelers,found that those who ... likely to suffer from clinically,significant diarrhea than their ...
Cached Medicine Technology:Targeted Genetics Announces Positive Phase 1/2 tgAAC94 Data Presented at Annual European Congress of Rheumatology 2Targeted Genetics Announces Positive Phase 1/2 tgAAC94 Data Presented at Annual European Congress of Rheumatology 3Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers' Diarrhea Vaccine 2Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers' Diarrhea Vaccine 3Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers' Diarrhea Vaccine 4Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers' Diarrhea Vaccine 5Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers' Diarrhea Vaccine 6Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers' Diarrhea Vaccine 7
... Blood glucose, medication, food, exercise, stress . ... a diabetes patients overall health. Unfortunately, its ... this vital information on a daily basis. ... day-to-day results or submit the information to ...
... The GlucoWatch G2 Biographer is intended ... glucose levels in adults (aged 18 and ... with diabetes. Parents should supervise the use ... The G2 Biographer is intended to supplement, ...
The ring maintains the bag tension avoiding the development of posterior capsule pleats. It is also established to compensate the efforts induced during the bag retraction....
Mayo dissecting scissors with beveled blades....
Medicine Products: